Viewing nowCombinationDapaM Duo Sustained Release Tablet 5/500 mg
Dapagliflozin Propanediol Hydrate 6.15mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
(Co., Ltd.) APROGEN Biologics

MFDS item code 202302655 · Approved 2023.09.06 · Insurance code 645210860
Improvement of glycemic control in adults with type 2 diabetes mellitus
This drug is used in combination with diet and exercise to help control blood sugar in adults with type 2 diabetes, using dapagliflozin and metformin. It should be administered with caution according to expert guidelines, especially in patients with cardiovascular disease or risk factors whose blood sugar is not sufficiently controlled. This drug is effectively used to improve blood sugar management in diabetic patients.
The dose of this medicine should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg. This medicine is generally administered once daily with the evening meal. The maximum dose of this medicine is dapagliflozin 10mg/extended-release metformin 2000mg once daily, given as two 5mg/1000mg tablets. Patients who have not previously received antidiabetic drug therapy and whose blood glucose is not adequately controlled with monotherapy: When used as initial therapy in patients who have not previously received antidiabetic drug therapy, the recommended starting dose of this medicine is one 5mg/500mg or 10mg/500mg tablet once daily. Increase the dose gradually to reduce gastrointestinal adverse reactions associated with metformin. For patients receiving metformin, the recommended dose of dapagliflozin is 10mg once daily. The dose of this medicine should provide the patient's current metformin dose or the nearest appropriate therapeutic dose. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted as appropriate. For patients switching to this medicine from combination therapy with dapagliflozin and metformin, this medicine may be started at the doses of dapagliflozin and metformin the patient was previously taking. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted as appropriate. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering drugs. Because changes may result in altered blood glucose control, any change in treatment for patients with type 2 diabetes should be made with careful monitoring. Swallow this medicine whole. Do not crush, cut, or chew it. Occasionally, inactive ingredients in this medicine may be excreted in the stool as a soft, hydrated mass resembling a tablet. Renal impairment No dosage adjustment is necessary in patients with mild renal impairment. In patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or more and less than 60 mL/min/1.73 m2 who do not have other symptoms that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this medicine, is 500mg once daily, and the maximum daily dose is 1000mg. Use of this medicine is not recommended in patients with an eGFR below 45 mL/min/1.73m2. If the estimated glomerular filtration rate (eGFR) falls below 45 mL/min/1.73m2, discontinue this medicine immediately. Renal function should be assessed every 3~6 months. Elderly patients Since metformin is excreted by the kidneys and renal function is likely to decline in elderly patients, this medicine should be used with caution with increasing age (see Precautions for Use, 9. Administration to Elderly Patients).
This drug is an antidiabetic medication that helps in controlling blood sugar. It may very rarely cause a serious metabolic disorder called lactic acidosis, which can be life-threatening; therefore, caution is needed. When used in combination with other antidiabetic drugs, there is a risk of hypoglycemia, so blood sugar levels should be closely monitored. This drug should not be used in patients with significantly impaired kidney function, serious infection or dehydration, type 1 diabetes patients, pregnant or nursing women, etc. Patients undergoing surgery or those undergoing tests using iodine contrast agents should temporarily discontinue this drug and restart it after confirming normal kidney function. Elderly patients or those with compromised kidney function should regularly check kidney function and fluid status before and after taking this drug, and carefully observe for any symptoms of hypotension or dehydration. This drug may increase the risk of genital and urinary tract infections, so if infection symptoms appear, medical consultation should be sought immediately. The metformin component may lower vitamin B12 levels, thus checking vitamin B12 levels regularly during long-term use is advisable. Excessive alcohol consumption should be avoided, and it is preferable to limit alcohol intake during treatment. This drug may need to be temporarily discontinued in situations of difficult blood sugar control, and dosage adjustments of insulin or other antidiabetic agents may be required to prevent hypoglycemia. Pregnant women or women who may become pregnant should avoid taking this drug, and it is also best for nursing mothers not to use it. There may be risks of dizziness or hypoglycemia when driving or operating machinery while taking this drug, so caution is advised. Keep out of reach of children and store in the original container to prevent misuse or degradation of quality.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly closed container to avoid exposure to air or moisture. Additionally, it is advisable to store the medication at room temperature between 1 degree and 30 degrees Celsius, avoiding very hot or very cold places.
Orange rectangular sustained-release film-coated tablet
28 tablets/box [7 tablets/PTP x 4]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin Propanediol Hydrate 6.15mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
(Co., Ltd.) APROGEN Biologics
Metformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
Metformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
YouYoung Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
Yuyoung Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.